Susan Goobie: Pediatric Transfusion Rates and Risks Spike
Susan Goobie, Pediatric Anesthesiologist at Boston Children’s Hospital, posted on LinkedIn:
”Our BJA Transfusion Outcomes in Paediatric Surgical Patients (TOPS) study reports that perioperative paediatric red blood cell transfusion trended upward over the past decade, with an overall transfusion rate of 6.3% and of 13.3% in neonates.
The 30-day mortality rate in those transfused was 2.4%, and was 14.9% in neonates, compared with 0.2% in the non-transfusion group.
We report an overall 1.2- to 5.2-fold increased rate of morbidity and 2-fold increased rate of mortality in the cohort exposed to RBC transfusion perioperatively compared with the cohort who did not receive blood.
Which surgical procedures associated with the highest probability of blood transfusion?
Is there an increased risk of infection in the transfused patients?
Does the total transfusion volume matter?
How can patient blood management be used to decrease transfusion exposure in neonates, children and adolescents?
Read our article – free to download for 50 days.”
Title: Transfusion and outcomes in paediatric surgical patients: an 11-year retrospective North American cohort study
Authors: Susan Goobie, David Faraoni
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis